id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2167-0006,FDA,FDA-2020-E-2167,Determination of Regulatory Review Period for Purposes of Patent Extension; QINLOCK,Notice,Determinations,2021-11-16T05:00:00Z,2021,11,2021-11-16T05:00:00Z,2022-01-19T04:59:59Z,2021-11-16T18:16:22Z,2021-24978,0,0,0900006484e4dfcd
FDA-2020-E-2167-0005,FDA,FDA-2020-E-2167,Patent Term Extension letter from FDA CDER to The Honorable Drew Hirshfield,Other,Letter(s),2021-11-05T04:00:00Z,2021,11,2021-11-05T04:00:00Z,,2021-11-05T15:06:14Z,,0,0,0900006484e2593f
FDA-2020-E-2167-0004,FDA,FDA-2020-E-2167,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2021-10-14T04:00:00Z,2021,10,2021-10-14T04:00:00Z,,2021-10-14T17:22:40Z,,0,0,0900006484dc58e0